Status:

COMPLETED

Drivers of Suicide Mobile App Study

Lead Sponsor:

Evidence-Based Practice Institute, Seattle, WA

Collaborating Sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions:

Suicide

Suicide, Attempted

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The central purpose of this project is to evaluate and facilitate access to evidence-based best practices for individuals struggling with suicidal ideation and co-occurring behavioral problems, includ...

Detailed Description

This study will test the newly developed WisePath for Adults ("WisePath"), a robust digital technology developed under NIAAA SBIR Fast-Track award (R44AA029868; Drs. Dimeff \& Jobes, Co-PIs) that is d...

Eligibility Criteria

Inclusion

  • Resides in the United States
  • 22+ years of age
  • English speaking
  • At risk for suicide, as evidenced by at least one of the following:
  • One or more lifetime suicide attempts (ASQ item 4)
  • Endorsement of any ASQ items 1 -3 (expanded from "past few weeks" in ASQ to "past 30 days" in our measures)
  • Item 1: In the past 30 days, have you wished you were dead?
  • Item 2: In the past 30 days, have you felt that you or your family would be better off if you were dead?
  • Item 3: In the 30 days, have you been having thoughts about killing yourself?
  • Currently has a primary care provider and sought care from them in the past year
  • Possesses and is the primary user of an Android- or iPhone-based smartphone with a data plan
  • Given that alcohol misuse exponentially increases the risk of death by suicide, can exacerbate other problems, and interfere with effective treatment, we will over-recruit individuals who misuse alcohol to ensure relevance of the tool for them. No fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking.
  • To ensure a sufficient sample of individuals who misuse alcohol, no fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking.

Exclusion

  • Severe depression (PHQ-9 score of 20 or greater)
  • Alcohol dependence (AUDIT score of 32 or greater)
  • Acutely suicidal (affirms item 5 of the Ask Suicide Screening Questions; Are you having thoughts of killing yourself right now? Followed by endorsing intent; Have you intended to act on urges to kill yourself in the past 30 days? or planning within the past 30 days; Have you made a plan to kill yourself in the past 30 days?)
  • Significant drug abuse problems (scores 6 or greater on the DAST-10)
  • Individuals who are excluded because of the severity of their depression, suicide acuity, and/or degree of substance use disorder will be provided with resources (i.e., the Suicide and Crisis Lifeline (988), SAMHSA's National Helpline) and encouraged to reach out to their primary care or mental/behavioral health provider.

Key Trial Info

Start Date :

March 5 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 10 2025

Estimated Enrollment :

127 Patients enrolled

Trial Details

Trial ID

NCT05427734

Start Date

March 5 2025

End Date

November 10 2025

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Evidence-Based Practice Institute, Inc.

Seattle, Washington, United States, 98126